Digital diabetes management: With insights at home and abroad, where should today’s business model head?
“Maybe the next time you get a prescription from the doctor, it will be an APP, but no longer just medicine,” noted Statenews, a prominent medical journal, when envisioning the prospect of digital health. The journal also deemed digital therapy a powerful yet provocative new idea in health care, whose software brings precision to therapy and enables personalized treatment. This gives digital therapy a big role to play as we transition to value-based care.
On the heels of a growing integration between AI, big data technology and medical healthcare, digital therapeutics (DTx), designed to treat, manage or prevent diseases by software-driven and evidence-based program, came on our radar. In particular, it is of great value for managing chronic diseases, such as hypertension and diabetes, which strongly correlate with patients’ lifestyles and behaviors.
Across the globe, the number of chronic diseases patients, especially diabetics, is on the upswing annually. Once there is a declining patient compliance in such key parameters as blood glucose monitoring and medication, more complications of diabetes and heavier disease burden will ensue. Digital healthcare’s emergence as a viable solution to diabetes management lies in its low cost, high accessibility and high-frequency intervention in patient’s lifestyles, all of which can strengthen the self-management of patients and increase their compliance. It also speaks of why diabetes digital management has become such a cutthroat market sector for ambitious enterprises. Over the past decade, a great number of leading chronic disease management enterprises, such as WellDoc, Omada, Dnurse, Glooko and Livongo, have come to the fore.
Comentarios